The Japanese drug maker Eisai on Thursday said it would withdraw the weight-loss drug Belviq from the U.S. market after the Food and Drug Administration expressed concerns about an increased occurrence of cancer reported in people who used the product.
The agency recommended that people using Belviq to lose weight should stop taking the medicine immediately, although the FDA is not recommending special cancer screening for people who have used the drug.
“We are taking this action because we believe that the risks of lorcaserin outweigh its benefits based on our completed review of results from a randomized clinical trial assessing safety,” the FDA statement said. Lorcaserin is the scientific name for Belviq.
About the Author Reprints
I am outraged at the stupidity of those who allowed this drug to “hit the market!” Because members of the FDA obviously did NOT do their due diligence, innocent people died! For Shame!!!
More specifics, but still pretty vague. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market
not worth it, exercise ALWAYS the way to go, another class action …..
What types of cancer?
pancreatic, colorectal and lung.